Results 281 to 290 of about 62,786 (347)

Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink   +4 more
wiley   +1 more source

The interplay between heart failure and chronic kidney disease

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) and heart failure (HF) are two globally prevalent, independent, long‐term conditions, which often coexist in an individual and display a bidirectional yet interconnected relationship. The presence of CKD often leads to the development of HF and vice versa, which propagates the worsening of each disease, reflecting ...
Anuradha Lala   +2 more
wiley   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano   +9 more
wiley   +1 more source

Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To determine the adherence rate in users of each class of glucose‐lowering medication and identify the key socio‐demographic factors influencing adherence. Methods The 45 and Up Study is an ongoing cohort study of residents aged ≥45 years in New South Wales, Australia.
Crystal M. Y. Lee   +3 more
wiley   +1 more source

Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes. [PDF]

open access: yesDiabetes Obes Metab
Shen J   +14 more
europepmc   +1 more source

Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the association between type 2 diabetes and all‐cause mortality in people with ischaemic and non‐ischaemic heart failure (HF). Methods Using the Clinical Practice Research Datalink primary care data, linked to hospital and mortality records, we identified newly diagnosed adults with type 2 diabetes between 2000 and 2021 and
Kajal Panchal   +4 more
wiley   +1 more source

Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation. [PDF]

open access: yesCardiovasc Diabetol
Chua SK   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy